Cite
Anticoagulation with nafamostat mesilate during extracorporeal life support.
MLA
Lang, Yuheng, et al. “Anticoagulation with Nafamostat Mesilate during Extracorporeal Life Support.” International Journal of Cardiology, vol. 366, Nov. 2022, pp. 71–79. EBSCOhost, https://doi.org/10.1016/j.ijcard.2022.07.022.
APA
Lang, Y., Zheng, Y., Qi, B., Zheng, W., Wei, J., Zhao, C., Gao, W., & Li, T. (2022). Anticoagulation with nafamostat mesilate during extracorporeal life support. International Journal of Cardiology, 366, 71–79. https://doi.org/10.1016/j.ijcard.2022.07.022
Chicago
Lang, Yuheng, Yue Zheng, Bingcai Qi, Weifeng Zheng, Jin Wei, Chengxiu Zhao, Wenqing Gao, and Tong Li. 2022. “Anticoagulation with Nafamostat Mesilate during Extracorporeal Life Support.” International Journal of Cardiology 366 (November): 71–79. doi:10.1016/j.ijcard.2022.07.022.